GSA Capital Partners LLP Decreases Stake in Oscar Health, Inc. (NYSE:OSCR)

GSA Capital Partners LLP cut its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 67.8% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 37,508 shares of the company’s stock after selling 78,923 shares during the quarter. GSA Capital Partners LLP’s holdings in Oscar Health were worth $796,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in shares of Oscar Health by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company’s stock valued at $216,846,000 after acquiring an additional 337,850 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in Oscar Health by 153.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock valued at $59,156,000 after purchasing an additional 2,409,160 shares during the period. Renaissance Technologies LLC boosted its holdings in Oscar Health by 31.7% in the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock worth $61,478,000 after purchasing an additional 934,600 shares during the last quarter. First Light Asset Management LLC grew its position in Oscar Health by 117.3% in the 1st quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company’s stock worth $31,265,000 after purchasing an additional 1,134,919 shares during the period. Finally, Assenagon Asset Management S.A. grew its position in Oscar Health by 32.9% in the 2nd quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock worth $32,368,000 after purchasing an additional 507,009 shares during the period. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Stock Down 3.7 %

OSCR stock opened at $14.87 on Friday. The business’s 50-day moving average price is $18.20 and its 200-day moving average price is $18.27. The stock has a market cap of $3.60 billion, a P/E ratio of -247.83 and a beta of 1.67. The company has a quick ratio of 0.91, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a twelve month low of $6.93 and a twelve month high of $23.79.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). The firm had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The business’s revenue for the quarter was up 68.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.29) earnings per share. On average, equities research analysts forecast that Oscar Health, Inc. will post -0.01 EPS for the current year.

Insider Transactions at Oscar Health

In related news, Vice Chairman Joshua Kushner bought 276,040 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The stock was bought at an average cost of $13.58 per share, with a total value of $3,748,623.20. Following the completion of the purchase, the insider now owns 5,031,262 shares of the company’s stock, valued at approximately $68,324,537.96. The trade was a 5.80 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Thrive Partners Vii Growth Gp, purchased 420,819 shares of the firm’s stock in a transaction on Tuesday, November 12th. The stock was bought at an average price of $13.68 per share, for a total transaction of $5,756,803.92. Following the purchase, the director now owns 5,452,081 shares in the company, valued at approximately $74,584,468.08. This represents a 8.36 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 1,055,478 shares of company stock valued at $14,432,852 and sold 169,569 shares valued at $3,007,069. Corporate insiders own 25.11% of the company’s stock.

Analyst Ratings Changes

OSCR has been the topic of a number of research reports. UBS Group began coverage on Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target on the stock. Piper Sandler reissued an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. Finally, Bank of America downgraded Oscar Health from a “neutral” rating to an “underperform” rating and cut their price target for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $22.93.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.